Oxaliplatin analogues with carboxy derivatives of boldine with enhanced antioxidant activity

Marco Mellado, Carlos Jara, David Astudillo, Joan Villena, Patricio G. Reveco, Franz A. Thomet

Research output: Contribution to journalArticlepeer-review

3 Scopus citations


A new oxaliplatin analog [Pt(dach)(L5)] (1) was synthesized and characterized as a continuation of a study of the previously reported [Pt(dach)(L6)] (2), where dach = (1R,2R)-diaminocyclohexane, L5 = 3-carboxyboldine, and L6 = 3-carboxypredicentrine. Compounds 1 and 2 exhibited a substantially enhanced antioxidant activity compared to oxaliplatin (130 and 30 times for 1 and 13 and 4 times for 2 using the DPPH and FRAP assays, resp.). In addition, 1 and 2 exhibited cytotoxic activity in the same range as oxaliplatin toward the two human tumor cell lines (MCF-7 and HT-29) studied and two to four times lower activity in the human colon nontumor cell line (CCD-841). Preadministration of L5 or L6 to the colon tumor (HT-29) and the colon nontumor (CCD-841) cell lines prior to oxaliplatin addition increased the viability of the nontumor cell line to a greater extent than that of the tumor cell line.

Original languageEnglish
Article number920143
JournalBioinorganic Chemistry and Applications
StatePublished - 28 Feb 2015
Externally publishedYes


Dive into the research topics of 'Oxaliplatin analogues with carboxy derivatives of boldine with enhanced antioxidant activity'. Together they form a unique fingerprint.

Cite this